Original language | English |
---|---|
Pages | 376s |
Publication status | Published - 1 Jan 2003 |
Salmeterol 50(ug) bid significantly increases through fev(i) in COPD up to 12 months without loss of effect
Robert Stockley, MK Williams, PJ Whitehead
Research output: Contribution to conference (unpublished) › Paper